Ketogenic diet and cancer treatment
Keywords:Diet; Ketogenic diet; Cancer; Chronic diseases.
Faced with an expressive increase in the last decades in the case of cancer in the world population, the need for a dietary strategy supporting conventional treatment for patients diagnosed with cancer has become evident, with the aim of obtaining positive results in the fight against the disease. This literature review study aimed to present the ketogenic diet (KD) as a nutritional intervention and its proposed mechanisms against cancer cells, as well as to characterize limitations in the literature currently available. The studies were selected from the BIREME, PUBMED, ScienceDirect databases, as well as books, institutional and government websites; using descriptors such as: ketogenic diet; chronic diseases; cancer; cancer treatment and oxidative stress; they were used in the English language. It has been proposed that, in the absence of blood glucose, cancer cells decrease their proliferation and enter a state of oxidative stress, as a consequence of a high-fat, carbohydrate-deficient diet, thus making them more sensitive to standardized treatments. such as radiation and chemotherapy. However, there is a need for further studies in humans in order to obtain better results and conclusions regarding this nutritional intervention.
Allen, B. G. et. al. (2014). Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism. Redox Biology, 2, 963-970,https://doi.org/10.1016/j.redox.2014.08.002
Arends, J. et al. (2017) ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition,36. 11-48,.https://doi.org/10.1016/j.clnu.2016.07.015
Cavalcanti (2017), A. Dieta Cetogênica: como colocar em prática? https://www.vponline.com.br/portal/noticia/pdf/1abbe95a4073913f5e17fdaa9fe0fe17.pdf
Fernandes, DP, Coutinho, VEA, Medeiros, L. de B., & Pereira, NLV (2020). Nutrientes e compostos bioativos na modulação epigenética associada à prevenção e combate ao câncer. Research, Society and development , 9 (4), e114942914. https://doi.org/10.33448/rsd-v9i4.2914
Gatenby, R., et al .(2004). Why do cancers have high aerobic glycolysis? Nat Rev Cancer,. 4, 891-899, https://doi.org/10.1038/nrc1478
Gray, A., Dang, B. N., Moore, T. B., Clemens, R., & Pressman, P. (2020). A review of nutrition and dietary interventions in oncology. SAGE Open Medicine. https://doi.org/10.1177/2050312120926877
INCA (2020). Estimativa 2020: incidência de câncer no Brasil. https://www.inca.gov.br/publicacoes/livros/estimativa-2020-incidencia-de-cancer-no-brasil .
Klement R. J. (2017). Beneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation. Medical oncology (Northwood, London, England), 34(8), 132. https://doi.org/10.1007/s12032-017-0991-5
Liu, Y.-m.C. (2008). Medium-chain triglyceride (MCT) ketogenic therapy. Epilepsia, 49: 33-36. https://doi.org/10.1111/j.1528-1167.2008.01830.x
Liu, Y. M., & Wang, H. S. (2013). Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomedical journal, 36(1), 9–15. https://doi.org/10.4103/2319-4170.107154
Midori, L.(2008). Dieta Cetogênica e Dieta Atkins Modificada no Tratamento da Epilepsia Refratária em Crianças e Adultos. J. Epilepsy Clin Neurophysiol, 14(2), 65-69. https://doi.org/10.1590/S1676-26492008000200005
Oliveira, C., Mattingly, S., Schirrmacher, R., Sawyer, M. B., Fine, E. J., & Prado, C. M. (2018). A Nutritional Perspective of Ketogenic Diet in Cancer: A Narrative Review. Journal of the Academy of Nutrition and Dietetics, 118(4), 668–688. https://doi.org/10.1016/j.jand.2017.02.003
Plotti, F., Terranova, C., Luvero, D., Bartolone, M., Messina, G., Feole, L., Cianci, S., Scaletta, G., Marchetti, C., Di Donato, V., Fagotti, A., Scambia, G., Benedetti Panici, P., & Angioli, R. (2020). Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment. Chemotherapy, 65(3-4), 77–84. https://doi.org/10.1159/000510839
Schoeler, N. E., & Cross, J. H. (2016). Ketogenic dietary therapies in adults with epilepsy: a practical guide. Practical neurology, 16(3), 208–214. https://doi.org/10.1136/practneurol-2015-001288
Soares, J. A. et al. (2017). Dieta Cetogênica Como Terapia Adjuvante ao Tratamento do Câncer. Anais Do I Congresso Multidisciplinar De Oncologia, 1, 53-54. https://acervomais.com.br/index.php/saude/article/view/153/60
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009). The cancer genome. Nature, 458(7239), 719–724. https://doi.org/10.1038/nature07943
Sousa, JC de, Altino, IP, Andrade, SM de, Cunha, MA, Araújo, BAC de, & Oliveira, EH de. (2020). Dieta cetogênica para pacientes com diabetes mellitus tipo II. Research, Society and development, 9 (7), e117973972. https://doi.org/10.33448/rsd-v9i7.3972.
Tan Shalaby, Jocelyn & Seyfried, Thomas. (2013). Ketogenic Diet in Advanced Cancer: A Pilot Feasibility and Safety Trial in the Veterans Affairs Cancer Patient Population. J Clinical Trials. 3. 10.4172/2167-0870.1000149.
Talib, W. H., Mahmod, A. I., Kamal, A., Rashid, H. M., Alashqar, A., Khater, S., Jamal, D., & Waly, M. (2021). Ketogenic Diet in Cancer Prevention and Therapy: Molecular Targets and Therapeutic Opportunities. Current issues in molecular biology, 43(2), 558–589. https://doi.org/10.3390/cimb43020042
Yang, Y. F., Mattamel, P. B., Joseph, T., Huang, J., Chen, Q., Akinwunmi, B. O., Zhang, C., & Ming, W. K. (2021). Efficacy of Low-Carbohydrate Ketogenic Diet as an Adjuvant Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients, 13(5), 1388. https://doi.org/10.3390/nu13051388
Yeou-mei, C. L. (2008). Medium-chain triglyceride (MCT) ketogenic therapy. Epilepsia, 49(8), 1-133 https://doi.org/10.1111/j.1528-1167.2008.01830.x
Warburg O. (1956). On the origin of cancer cells. Science (New York, N.Y.), 123(3191), 309–314. https://doi.org/10.1126/science.123.3191.309
Weber, D. D., Aminzadeh-Gohari, S., Tulipan, J., Catalano, L., Feichtinger, R. G., & Kofler, B. (2020). Ketogenic diet in the treatment of cancer - Where do we stand?. Molecular metabolism, 33, 102–121. https://doi.org/10.1016/j.molmet.2019.06.026
How to Cite
Copyright (c) 2022 Daniel Donato de Sousa; João Gabriel Toledo Pacheco Silva; Dayanne da Costa Maynard
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.